Table 5.

Comparison of PAC and log PAC between total, men, and women participants with and without OSA by presence of hypertension and by age in community-based data.

	Untreated hypertension			Normotension
	Non-OSA	OSA	P	Non-OSA	OSA	P
N	3,775	2,642		15,951	3,000
PAC (median, interquartile range)
Men	12.2 (8.7,17.5)	13.4 (9.3,19.2)	<0.001	13.0 (9.2,18.4)	14.4 (10.1,20.4)	<0.001
<45 years	12.8 (9.1,18.4)	14.0 (9.5,20.0)	0.025	12.9 (9.1,18.4)	15.6 (10.6,21.0)	<0.001
45–60 years	12.2 (8.6,17.4)	14.0 (9.6,20.0)	<0.001	13.2 (9.3,18.5)	14.9 (10.3,21.1)	<0.001
≥60 years	10.3 (7.9,15.8)	12.5 (8.9,17.3)	<0.001	12.7 (9.1,17.5)	13.0 (9.4,18.2)	0.403
Women	15.0 (10.8,20.9)	14.2 (10.5,19.7)	0.010	16.0 (11.2,23.1)	14.0 (10.6,18.9)	<0.001
<51 years	17.3 (12.2,22.8)	16.3 (11.4,23.6)	0.007	16.6 (11.5,24.1)	17.8 (11.7,23.4)	0.841
≥51 years	14.6 (10.7,20.3)	14.10 (10.5,19.3)	<0.001	14.3 (10.7,19.9)	14.0 (10.4,18.5)	0.061
Log plasma aldosterone concentration (mean ± standard deviation)
Men	2.09 ± 0.20	2.13 ± 0.20	<0.001	2.12 ± 0.20	2.16 ± 0.20	<0.001
<45 years	2.11 ± 0.20	2.14 ± 0.20	0.043	2.12 ± 0.20	2.18 ± 0.20	<0.001
45-60 years	2.09 ± 0.20	2.15 ± 0.20	<0.001	2.12 ± 0.20	2.17 ± 0.20	<0.001
≥60 years	2.05 ± 0.20	2.10 ± 0.19	0.001	2.11 ± 0.20	2.13 ± 0.20	0.362
Women	2.18 ± 0.20	2.17 ± 0.20	0.015	2.22 ± 0.23	2.16 ± 0.19	<0.001
<51 years	2.23 ± 0.23	2.20 ± 0.20	0.001	2.23 ± 0.23	2.23 ± 0.18	0.915
≥51 years	2.12 ± 0.18	2.17 ± 0.19	<0.001	2.16 ± 0.19	2.15 ± 0.19	0.043

PAC, plasma aldosterone concentration.